Leads from the MMWR. Lack of transmission of human immunodeficiency virus through Rho(D) immune globulin (human).
出版信息
JAMA. 1987 Dec 11;258(22):3225.
PMID:2824867
Abstract
摘要
相似文献
1
2
Lack of transmission of human immunodeficiency virus through Rho(D) immune globulin (human).人类免疫缺陷病毒不会通过人源Rho(D)免疫球蛋白传播。
MMWR Morb Mortal Wkly Rep. 1987 Nov 13;36(44):728-9.
3
Further fears of HIV in India.印度对艾滋病病毒的进一步恐惧。
Nature. 1989 Feb 9;337(6207):496. doi: 10.1038/337496c0.
4
Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.治疗性免疫球蛋白制剂与人嗜T淋巴细胞病毒III型/淋巴结病相关病毒感染传播的安全性。
MMWR Morb Mortal Wkly Rep. 1986 Apr 11;35(14):231-3.
5
Lack of HIV transmission after hepatitis B immunoprophylaxis.乙肝免疫预防后未发生HIV传播。
Infection. 1987;15(5):366. doi: 10.1007/BF01647744.
6
Hepatitis B immune globulin and human immunodeficiency virus antibody.乙型肝炎免疫球蛋白和人类免疫缺陷病毒抗体。
CMAJ. 1988 Sep 15;139(6):520.
7
8
Safety of immune globulin preparations.免疫球蛋白制剂的安全性。
CMAJ. 1988 Sep 15;139(6):522.
9
Rho(D) immune globulin: pros, cons, indications, and alternatives.Rho（D）免疫球蛋白：利弊、适应症及替代方案。
Birth Gaz. 1999 Spring;15(2):18-21.
10
[Anti-D contaminating human thrombin].[抗-D污染人凝血酶]
Sangre (Barc). 1986;31(4):507.
引用本文的文献
1
Missed anti-D immune globulin administration to postpartum patients in 2 health systems: an unrecognized patient safety risk.两家医疗系统中产后患者漏用抗-D免疫球蛋白：一种未被认识到的患者安全风险。
AJOG Glob Rep. 2022 Feb 5;2(2):100038. doi: 10.1016/j.xagr.2021.100038. eCollection 2022 May.
Zotero 插件